Results 101 to 110 of about 24,423 (115)

Pharmacodynamics of combined estrogen–progestin oral contraceptives: 4. Effects on uterine and cervical epithelia

Expert Review of Clinical Pharmacology, 2020
Carlo Bastianelli, Manuela Farris, Vincenzina Bruni   +2 more
exaly  

Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: The role of the progestogen type and estrogen dose

Thrombosis Research, 2018
Carina Oedingen, Stefan Scholz, Oliver Razum   +2 more
exaly  

The Quality of Information on Combined Oral Contraceptives Available on the Internet

Journal of Obstetrics and Gynaecology Canada, 2019
Neşe Yuksel
exaly  

The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives

European Journal of Contraception and Reproductive Health Care, 2000
R A Lawrenson, T J Williams, K D Macrae
exaly  

Epidemiological and clinical aspects of migraine in users of combined oral contraceptives

Contraception, 2010
Rogerio Bonassi Machado
exaly  

The effects of oral contraceptives on mood and sexuality: A comparison of triphasic and combined preparations

Journal of Psychosomatic Obstetrics and Gynaecology, 1987
J Bancroft, Pamela Warner
exaly  

Pharmacodynamics of combined estrogen-progestin oral contraceptives 3. Inhibition of ovulation

Expert Review of Clinical Pharmacology, 2018
Carlo Bastianelli, Manuela Farris, Elena Rosato   +2 more
exaly  

Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis

Expert Review of Clinical Pharmacology, 2017
Manuela Farris, Carlo Bastianelli, Elena Rosato   +2 more
exaly  

Letrozole combined with oral contraceptives versus oral contraceptives alone in the treatment of endometriosis-related pain symptoms: a pilot study

Gynecological Endocrinology, 2021
exaly  

ORAL CONTRACEPTIVES AND OVARIAN CANCER RISK

Ca-A Cancer Journal for Clinicians, 2008
exaly